The morphological and biochemical consequeiices of treatment of human peripheral blood leukocytes with cytochalasin B were studied. Incubation of human polymorphs with cytochalasin B resulted in nuclear and cytoplasmic spreading, but not in spontaneous release of lysosomal enzymes. Cytochalasin B inhibited particle uptake. Consequently, phagocytic vacuoles were not observed; instead, granule contents were discharged directly into the surrounding medium when cytochalasin B-treated cells were challenged with zymosan particles. Considerable experimental evidence suggests that release from cells of substances previously sequestered within lysosomes mediates, in part, acute inflammatory reactions and irreversible tissue damage (1-3). Inhibition, therefore, of lysosomal enzyme release from cells that participate in the inflammatory responpe may modify inflammation and subsequent tissue injury. Release of enzymes or secretion of substances from living cells depends on the intracellular traffic of granules to the cell periphery. Consequently, interference with flow and merger of granules might lead to reduction in enzyme release. Intracellular movement of lysosomes may be guided, in an as yet undetermined manner, by microtubules (4, 5), the function of which, in turn, can be modified by cyclic nucleotides (6).
Considerable experimental evidence suggests that release from cells of substances previously sequestered within lysosomes mediates, in part, acute inflammatory reactions and irreversible tissue damage (1) (2) (3) . Inhibition, therefore, of lysosomal enzyme release from cells that participate in the inflammatory responpe may modify inflammation and subsequent tissue injury. Release of enzymes or secretion of substances from living cells depends on the intracellular traffic of granules to the cell periphery. Consequently, interference with flow and merger of granules might lead to reduction in enzyme release. Intracellular movement of lysosomes may be guided, in an as yet undetermined manner, by microtubules (4, 5) , the function of which, in turn, can be modified by cyclic nucleotides (6) .
We have -previously documented the selective release of lysosomal, but not cytoplasmic, enzymes from viable human leukocytes during phagocytosis of inert particles. Addition of cyclic AMP itself, of compounds such as prostaglandin E1 that influence the accumulation of cyclic nucleotides (7, 8) , or of drugs such as colchicine and vinblastine that directly affect microtubule integrity (9) (10) (11) , reduce extrusion of acid hydrolases from phagocytic cells (12) (13) (14) (15) . Therefore, it has been suggested (12) that agents that influence intracellular levels of cyclic nucleotides might regulate the movement of lysosomes to phagocytic vacuoles and/or to the cell periphery by virtue of effects upon microtubules.
However, at the concentrations used (1 mM in earlier experiments), colchicine inhibited particle uptake, while the other compounds also affected the metabolic consequences of particle uptake (13) , suggesting that reduced enzyme release might simply result from inhibition of phagocytosis per se. Nonetheless, the experiments did not exclude an additional effect of compounds on intracellular events subsequent to particle ingestion. Therefore, we designed experiments to study enzyme release independently of the engulfment phase of phagocytosis. In addition, we attempted to delineate the function of microtubules and microfilaments during enzyme release. To these ends, we have studied the effects of cytochalasin B, a fungal metabolite. This agent interferes with microfilament function, inhibits cell locomotion, markedly reduces ingestion of bacteria by human leukocytes (16) (17) (18) (19) (20) (21) (22) , and inhibits uptake of sugars and nucleosides in cultured cells (23) (24) (25) granules were present in the areas surveyed. Symbols are as follows: *P < 0.01 as compared to resting cells; **P < 0.01 as compared to untreated control cells that ingested zymosan or immune complex.
outside, pathways to the external medium through endocytic channels were observed. This mechanism of enzyme release has been termed "regurgitation during feeding," and is partially blocked by colchicine and agents that influence accumulation of cyclic nucleotides (12) .
Pharmacologic Inhibition of Degranulation. When cells were incubated with colchicine or with prostaglandin El and theophylline before exposure to zymosan, a greater number of lysosomes remained intact within the cell, presumably reflecting their failure to merge with phagosomes. This retardation of degranulation was quantitated ( ZYM.
FIG. 3. (A)
An untreated polymorphonuclear leukocyte that has ingested zymosan. At the upper right is a particle that has been bound to the cell, but not yet ingested. Notice the absence of lysosomes in the cytoplasmic region adjacent to the attached particle. In the lower portion of this picture is a zymosan (ZYM) particle in a phagocytic vacuole (arrow). Lysosomes surround the particle and many have degranulated-into the vacuole. Those with intact membranes are considerably less electron-dense than the lysosomes that have fused with the phagocytic vacuole. Magnification X 13,000. Bar = 1 pm. (B) A cytochalasin B-treated polymorphonuclear leukocyte that has been exposed to zymosan. The zymosan particle (ZYM) has been bound, but not ingested. In contrast to the situation in A, electrondense lysosomal contents are seen at the interface between the particle and the cell membrane (arrow). Magnification X 11,500. Bar = 1/m. lation can be drawn from the correlation between enzyme release and the morphological analyses.
Response of Cytochalaein B-Treated Leukocytes to Zymosan
Particles. An electron micrograph of a resting untreated human polymorphonuclear leukocyte is depicted in Fig. 2A . Three distinct zones were usually defined: (i) a leading edge of cytoplasmic extensions that contained few, if any, organelles; (ii) an area about the nuclear lobes where the majority of organelles including lysosomes, mitochondria, golgi apparatus, centriole, microtubules, (about 250 A) and microfilaments (about 100 i) were located; and (iii) a trailing section with a relatively smooth plasma membrane profile, containing additional lysosomes and microfilaments. The morphology of human polymorphonuclear leukocytes was altered profoundly by 15 min of incubation with 5 jug/ml of cytochalasin B (Fig. 2B) . Agranular cytoplasmic extensions were not evident. Microtubules did not differ in appearance from untreated cells. In contrast to untreated cells ( Fig. 2A) , in which the nuclear lobes were usually less than 1 pm apart, nuclear lobes were separated by distances of up to 4 pm. [This effect probably accounts for the "rosette nuclei" observed (21) by light microscopy in cytochalasin B-treated leukocytes.] In addition to nuclear spreading, the cytoplasm was similarly spread out, and the cell membrane had a lobulated profile that followed the contour of the nuclear lobes. Discharge of granule contents was not observed.
Incubation of leukocytes with 5 sg/ml of cytochalasin B for 15 min before exposure of cells to zymosan resulted in complete inhibition of particle uptake (Fig. 3B) . Zymosan particles adhered to the plasma membrane, but were not ingested. The cells again appeared spread out, and there was evidence of degranulation and cytoplasmic vacuolation. Microtubules appeared intact. Channels were observed to extend deeply into the cytoplasm, apparently formed by fusion of a chain of granules, and discharge of electron-dense granule contents to the outside of the cell was observed at the cell-zymosan interface (Fig. 3B) .
The biochemical correlates of these morphological observations are shown in Fig. 4 . Phagocytosis of zymosan resulted in selective enzyme release. Cytochalasin B alone did not induce release of acid hydrolase, but when cells were challenged by zymosan particles after cytochalasin, substantial proportions of p3-glucuronidase were released into the medium.
Total activities of P-glucuronidase or lactate dehydrogenase did not change with these treatments, and there was no selective loss or adherence to cells of these enzymes.
Therefore it is likely that zymosan so affected the cell membrane as to cause the leukocyte granules to move toward it. Merger of granules with plasma membrane results in discharge of lysosomal enzymes directly to the outside of the cell, as though into a phagocytic vacuole. There was no significant release of cytoplasmic lactate dehydrogenase, and the cells remained viable. This mechanism of enzyme release has been termed "reverse endocytosis" (13) ; it is usually independent of particle uptake. Consequently, cytochalasin B-treated cells constitute an ideal model system with which to study mechanisms of lysosomal granule fusion.
We expected that treatment of cells with agents that retard movement of lysosomes toward the cell periphery would result in reduction of enzyme release. Incubation with 10 ,pM colchicine, with 50 uM vinblastine (not shown), or with compounds that influence the concentration within cells of cyclic nucleotides before exposure of human leukocytes to cytochalasin B and zymosan did, in fact, reduce extrusion of lysosomal enzymes (Fig. 4) .
Response of cytochalasin B-Treated Cells to Nonphagocytosable Stimuli. Although cytochalasin B inhibits antigenmediated histamine release from mast cells (28) , it also enhances glucose-induced secretion of insulin from islet cells of rat pancreas (29) . Similar release of greater amounts of total j3-glucuronidase from cytochalasin B-treated cells than from untreated cells exposed to zymosan suggested that cytochalasin B might augment lysosomal enzyme release. This possibility was tested with a second model for reverse endocytosis.
It has been demonstrated that the encounter between leukocytes and immune precipitates dispersed along a nonphagocytosable surface results in selective enzyme release by discharge of granule constituents directly to the outside of the cell (30) (31) (32) . The technique was adapted to our studies.
Millipore filters were coated with immune complexes made by reaction of heat-denatured (63°X 10 min) immunoglobulin G (IgG) with rheumatoid factor (IgM). Human leukocytes (6 X 106) suspended in Lucite chambers were allowed to settle onto the filter and were incubated at 370 for 2 hr. Under these circumstances, in the absence of phagocytosis, there was selective release of lysosomal enzymes ( Table 1 ). Agents that influence the concentration of intracellular cyclic nucleotides reduce enzyme extrusion in this experimental model (33) . Prior treatment of cells (15 min) with cytochalasin B resulted in augmentation of enzyme release ( Table 1 ). The noncoated filter did not induce significant enzyme release, even when cells were first treated with cytochalasin B (Table  1) . Again, as in the case of nonphagocytosable zymosan challenge, augmentation by cytochalasin B of enzyme extrusion was significantly reduced by the dibutyryl analogue of cyclic AMP and by prostaglandin El. Reduction of enzyme release by 0.1 mM colchicine was observed after 30 min of incubation of the cells on the filter, but not after 60 or 120 min. It appears that the effects of colchicine in this system, for some unknown reason are more rapidly reversible than in the previously described model.
DISCUSSION
The precise mechanism whereby cytochalasin B augments enzyme release from human leukocytes is not clear. It is not due to passive release from damaged cells. Examination of the electron micrographs indicates that in cytochalasin Btreated cells the constraints to granule movement are removed and granules pile together in a linear fashion. The shuttle and flow of leukocyte granules has been compared to the kind of directed intracellular traffic observed in secretory cells (34) . Pertinent, then, is the report that a cortical band of fine microfilaments is consistently observed in beta cells of rat pancreas, and that alteration of the microfilamentous web by cytochalasin B is associated with enhancement of glucose-induced secretion of insulin from isolated islets (29) . Moreover, the intracellular translocation of melanin granules within melanocytes is influenced by cytochalasin B (35, 36) , suggesting that microfilaments mediate dispersion of melanocyte-stimulating hormone-stimulated pigment granules. It is possible that cytochalasin B enhances particle-induced enzyme release in leukocytes by an effect on microfilaments. Henson has also reported that cytochalasin B (5 sg/ml) enhances release of 0-glucuronidase from human neutrophils exposed to immune complexes on nonphagocytosable surfaces (37) . In a medium containing added albumin, however, colchicine (0.1 MuM-1 mM) had little effect on release of ,-glucuronidase from human neutrophils reacting with aggregated gammaglobulin on nonphagocytosable surfaces (37) . These models are not directly comparable to the experiments we have described, and apparent discrepancies await resolution.
Unfortunately for this simple scheme, alteration of microfilament structure does not invariably accompany cytochalasin B treatment (38) , and it has been suggested that a direct effect of cytochalasin B on cell membranes may be responsible for its biological actions (16, 24, 39) . Cytochalasin B interacts with at least three membrane transport systems, since it inhibits transport of glucose, uridine, and thymidine into cells. The effects of cytochalasin B are reversed when cells are washed and cytochalasin B is removed from the medium (16, 20, 21, (23) (24) (25) 37) , indicating that its effects may be due to reversible binding of cytochalasin B to the membrane surface. Furthermore, although cytochalasin B can bind to proteins and change their physical properties (40) , there is no evidence that cytochalasin B accumulates in leukocytes.
Intracellular rearrangements appear to be accomplished by an as yet undefined interaction between microtubules, microfilaments, and cyclic nucleotides. Thus, dispersion of melanocyte granules is affected by cyclic AMP (41), by colchicine (42) , and by cytochalasin B (43) . Glucose-induced insulin secretion from pancreas and carbamylcholine stimulation of mucin secretion from submaxillary glands are both suppressed by colchicine (44) (45) (46) . Further evidence for an effect of cyclic AMP upon microtukules has been presented by Gillespie (47) . Colchicine binds to microtubule subunits that are in equilibrium with formed microtubules (48, 49) , and, in the absence of calcium ions, increased concentrations of cyclic AMP seemed to favor the disaggregation of formed tubules (a colchicine-like action). Since colchicine and vinblastine inhibited lysosomal enzyme extrusion from cells in which microfilaments no longer restrained flow of lysosomes to the plasma membrane, it is conceivable that the secretion of lysosomal enzymes depends upon the integrity of microtubules. Since phagocytosis seems not to depend upon endogenous cyclic AMP (8, 50) , a search for other cyclic nucleotides and their intracellular effectors seems in order.
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